Organogenesis Holdings Inc (ORGO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Sales | 564,169 | 482,043 | 433,140 | 450,893 | 467,359 |
| Cost of Goods | 137,522 | 115,741 | 106,481 | 105,019 | 114,199 |
| Gross Profit | 426,647 | 366,302 | 326,659 | 345,874 | 353,160 |
| Operating Expenses | 382,475 | 368,326 | 314,615 | 323,589 | 281,141 |
| Operating Income | 44,694 | -1,283 | 12,525 | 22,304 | 72,218 |
| Interest Expense | 0 | 0 | 0 | 2,009 | 7,236 |
| Other Income | 2,276 | -1,524 | -2,133 | -13 | -1,896 |
| Pre-tax Income | 46,970 | -2,807 | 10,392 | 20,282 | 63,086 |
| Income Tax | 9,938 | -3,668 | 5,447 | 4,750 | -31,116 |
| Net Income Continuous | 37,032 | 861 | 4,945 | 15,532 | 94,202 |
| Net Income | $37,032 | $861 | $4,945 | $15,532 | $94,202 |
| EPS Basic Total Ops | 0.16 | -0.01 | 0.04 | 0.12 | 0.73 |
| EPS Basic Continuous Ops | 0.29 | 0.01 | 0.04 | 0.12 | 0.73 |
| EPS Diluted Total Ops | 0.15 | -0.01 | 0.04 | 0.12 | 0.70 |
| EPS Diluted Continuous Ops | 0.28 | 0.01 | 0.04 | 0.12 | 0.70 |
| EPS Diluted Before Non-Recurring Items | 0.29 | -0.01 | 0.04 | 0.12 | 0.76 |
| EBITDA(a) | $71,632 | $24,091 | $35,974 | $40,335 | $88,894 |